About: COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions
Creator	Johnson, Steven Poeschla, Eric Krsak, Martin
Source	Medline; PMC; WHO
abstract	Public health measures are needed to resolve the novel coronavirus disease (COVID-19) pandemic, although a looming economic fallout merits close attention. Early safe reintroduction of immune individuals into the workforce may be essential to protecting the economic welfare of communities. Reverse transcriptase–polymerase chain reaction testing, our primary diagnostic tool to date, has sensitivity and timing concerns, owing to sampling/handling errors, as well as a complex virus–host interaction. Reverse transcriptase–polymerase chain reaction assays do not establish immune status once the virus has been cleared. Targeted serosurveillance for the determination of individuals’ potential for transmissibility, particularly if paired with direct pathogen testing, may aid in “cleared for business” decision-making.
has issue date	2020-04-23(xsd:dateTime)
bibo:doi	10.4269/ajtmh.20-0302
bibo:pmid	32329432
has license	cc-by
sha1sum (hex)	4463a7244d68fbbf2e379e1ccc8ba6e808c2efa7
schema:url	https://doi.org/10.4269/ajtmh.20-0302
resource representing a document's title	COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions
has PubMed Central identifier	PMC7253118
has PubMed identifier	32329432
schema:publication	Am J Trop Med Hyg
resource representing a document's body	covid:4463a7244d68fbbf2e379e1ccc8ba6e808c2efa7#body_text
is schema:about of	named entity 'MEASURES' named entity 'TIMING' named entity 'CLOSE' named entity 'TARGETED' named entity 'IMMUNE' named entity 'ECONOMIC' named entity 'PROTECTING' named entity 'SAMPLING' named entity 'pathogen' named entity 'primary' named entity 'economic' named entity 'cleared' named entity 'looming' named entity 'COVID-19' named entity 'Early' named entity 'economic welfare' named entity 'workforce' named entity 'Reverse transcriptase' named entity 'polymerase chain reaction' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'antibody' named entity 'reverse transcriptase' named entity 'COVID-19' named entity 'immune response' named entity 'clinically significant' named entity 'asymptomatic' named entity 'social distancing' named entity 'quarantine' named entity 'RT-PCR' named entity 'China National Health Commission' named entity 'April 1, 2020' named entity 'transmissibility' named entity 'RT-PCR' named entity 'SARS-CoV-2' named entity 'seropositive' named entity 'U.S. CDC' named entity 'SARS-CoV-2' named entity 'IgG' named entity 'antiviral' named entity 'RT-PCR' named entity 'handwashing' named entity 'Severe acute respiratory syndrome' named entity 'SARS' named entity 'antibody test' named entity 'primary infection' named entity 'serum' named entity 'antibody test' named entity 'transmissibility' named entity 'COVID-19' named entity 'RT-PCR' named entity 'viral shedding' named entity 'vaccines' named entity 'rechallenged' named entity 'serology' named entity 'public health' named entity 'polymerase chain reaction' named entity 'SARS-CoV-2' named entity 'antibody testing' named entity 'epidemiological' named entity 'COVID' named entity 'IgM' named entity 'asymptomatic' named entity 'RT-PCR' named entity 'antibody' named entity 'probability' named entity 'Food and Drug Administration' named entity 'virus' named entity 'SARS-CoV-2' named entity 'IgA' named entity 'RT-PCR' named entity 'sputum' named entity 'IgG antibody' named entity 'IgM' named entity 'United States' named entity 'symptom' named entity 'RT-PCR' named entity 'potentially infectious' named entity 'coronavirus disease'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software